Department of Diagnostic Radiology/Interventional Radiology Center, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 1040045, Japan.
Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Curr Oncol Rep. 2022 Aug;24(8):1035-1044. doi: 10.1007/s11912-022-01271-7. Epub 2022 Apr 1.
With the remarkable progress in cancer precision medicine, the demand for biopsy has been increasing, and the role of biopsy has been changing. In this review, we discuss the current state and recent advances in the role of image-guided percutaneous needle biopsy (PNB) in facilitating precision medicine.
Biopsies are useful not only in the diagnosis of cancer and histological sub-type but also in the analysis of its molecular characteristics for targeted treatments. PNB specimens have been shown to provide high DNA yields for genomic analysis. Liquid biopsy is an emerging technology but is under development; therefore, PNB is the current standard of practice and is performed complimentarily with liquid biopsy. In the age of precision medicine, interventional oncologists play a key role in optimal tissue collection for adequate genomic analysis. Effective PNB may improve its diagnostic utility and help optimize precision medicine.
随着癌症精准医学的显著进展,对活检的需求不断增加,活检的作用也在发生变化。在这篇综述中,我们讨论了在促进精准医学方面,影像引导经皮穿刺活检(PNB)的当前状态和最新进展。
活检不仅有助于癌症的诊断和组织学亚型的分析,而且还有助于对其分子特征进行分析以进行靶向治疗。PNB 标本已被证明可提供用于基因组分析的高 DNA 产量。液体活检是一种新兴技术,但仍在开发中;因此,PNB 是目前的标准实践,并与液体活检相辅相成。在精准医学时代,介入肿瘤学家在获得足够基因组分析的最佳组织采集方面发挥着关键作用。有效的 PNB 可能会提高其诊断效用,并有助于优化精准医学。